Patents by Inventor Deborah Parkes

Deborah Parkes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA encoding a novel PROST 03 polypeptide
    Publication number: 20020009455
    Abstract: The present invention relates to novel human polypeptides, designated PROST 03, which exhibit an expression pattern showing a high specificity toward prostate tissues, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to methods for utilizing the polynucleotides and polypeptides in research, diagnosis, and therapeutic applications.
    Type: Application
    Filed: April 20, 2001
    Publication date: January 24, 2002
    Inventors: Ted Lau, Richard J. Lin, Deborah Parkes, Gordon Parry, Douglas W. Schneider, Renate Steinbrecher, Pamela Toy Van Heuit, John Wu
  • DNA encoding a novel RG1 polypeptide
    Publication number: 20020004047
    Abstract: The present invention relates to novel human extracellular matrix polypeptides, designated RG1, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to methods for utilizing the polynucleotides and polypeptides in research, diagnosis, and therapeutic applications.
    Type: Application
    Filed: December 7, 2000
    Publication date: January 10, 2002
    Inventors: Richard Harkins, Deborah Parkes, Gordon Parry, Douglas W. Schneider, Renate Steinbrecher
  • Compositions and methods for FeLV vaccination
    Patent number: 5152982
    Abstract: Novel methods and compositions are provided for vaccinating a host susceptible to viral infection. Particularly, an initial injection is employed of one or more polypeptides associated with the host immune response to the pathogen followed by administration of the pathogen in attenuated form, particularly having a deletion associated with the gene expressing at least one of said polypeptides. In this manner, hosts may be vaccinated so as to maintain a strong defensive posture against infection from the pathogen. The method is specifically illustrated with feline leukemia virus.
    Type: Grant
    Filed: December 10, 1991
    Date of Patent: October 6, 1992
    Assignee: Chiron Corporation
    Inventors: Deborah Parkes, Paul Luciw, Gary Van Nest, Dino Dina